

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.32090630 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.19554203 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.13797276 |
| 4 | behavioral response to nicotine (GO:0035095) | 4.80478665 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.74302937 |
| 6 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.63870298 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.60964410 |
| 8 | regulation of synaptic vesicle transport (GO:1902803) | 4.58191526 |
| 9 | glutamate secretion (GO:0014047) | 4.36523691 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.29337769 |
| 11 | protein localization to synapse (GO:0035418) | 4.09855387 |
| 12 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.96508852 |
| 13 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.96508852 |
| 14 | transferrin transport (GO:0033572) | 3.96129207 |
| 15 | locomotory exploration behavior (GO:0035641) | 3.83286642 |
| 16 | neurotransmitter secretion (GO:0007269) | 3.78629187 |
| 17 | synaptic transmission, glutamatergic (GO:0035249) | 3.73201255 |
| 18 | vocalization behavior (GO:0071625) | 3.67617690 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.67058968 |
| 20 | trivalent inorganic cation transport (GO:0072512) | 3.66240226 |
| 21 | ferric iron transport (GO:0015682) | 3.66240226 |
| 22 | postsynaptic membrane organization (GO:0001941) | 3.61193719 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.53749963 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.50553569 |
| 25 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.48072936 |
| 26 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.44211304 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.43622324 |
| 28 | startle response (GO:0001964) | 3.42546312 |
| 29 | synaptic vesicle endocytosis (GO:0048488) | 3.42245815 |
| 30 | cellular response to ATP (GO:0071318) | 3.35470291 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.34149666 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 3.31811369 |
| 33 | phagosome maturation (GO:0090382) | 3.20188727 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.19884836 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.17171352 |
| 36 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.16995278 |
| 37 | response to pheromone (GO:0019236) | 3.16183296 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.16126391 |
| 39 | negative regulation of microtubule polymerization (GO:0031115) | 3.15069032 |
| 40 | urinary tract smooth muscle contraction (GO:0014848) | 3.14197214 |
| 41 | fucose catabolic process (GO:0019317) | 3.13948087 |
| 42 | L-fucose metabolic process (GO:0042354) | 3.13948087 |
| 43 | L-fucose catabolic process (GO:0042355) | 3.13948087 |
| 44 | exploration behavior (GO:0035640) | 3.13171000 |
| 45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.12710783 |
| 46 | vesicle docking involved in exocytosis (GO:0006904) | 3.12003589 |
| 47 | regulation of neurotransmitter secretion (GO:0046928) | 3.08872078 |
| 48 | neuronal action potential (GO:0019228) | 3.07081039 |
| 49 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.05621557 |
| 50 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.05502735 |
| 51 | positive regulation of membrane potential (GO:0045838) | 3.05353831 |
| 52 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.04279859 |
| 53 | detection of light stimulus involved in visual perception (GO:0050908) | 3.04279859 |
| 54 | establishment of synaptic vesicle localization (GO:0097480) | 3.02815869 |
| 55 | synaptic vesicle transport (GO:0048489) | 3.02815869 |
| 56 | neurotransmitter transport (GO:0006836) | 3.02315416 |
| 57 | neuromuscular synaptic transmission (GO:0007274) | 3.01607095 |
| 58 | primary amino compound metabolic process (GO:1901160) | 3.01497584 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.98982390 |
| 60 | cAMP catabolic process (GO:0006198) | 2.96219606 |
| 61 | clathrin coat assembly (GO:0048268) | 2.95977597 |
| 62 | serotonin metabolic process (GO:0042428) | 2.94790368 |
| 63 | presynaptic membrane assembly (GO:0097105) | 2.93599434 |
| 64 | glutamate receptor signaling pathway (GO:0007215) | 2.92550703 |
| 65 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.90255258 |
| 66 | regulation of action potential (GO:0098900) | 2.89415386 |
| 67 | activation of protein kinase A activity (GO:0034199) | 2.88918313 |
| 68 | cyclic nucleotide catabolic process (GO:0009214) | 2.87911204 |
| 69 | membrane hyperpolarization (GO:0060081) | 2.87151617 |
| 70 | transmission of nerve impulse (GO:0019226) | 2.87039932 |
| 71 | regulation of neurotransmitter levels (GO:0001505) | 2.84335839 |
| 72 | vesicle docking (GO:0048278) | 2.82031348 |
| 73 | membrane depolarization (GO:0051899) | 2.81917499 |
| 74 | positive regulation of synapse maturation (GO:0090129) | 2.81616881 |
| 75 | presynaptic membrane organization (GO:0097090) | 2.80757582 |
| 76 | behavioral fear response (GO:0001662) | 2.80692503 |
| 77 | behavioral defense response (GO:0002209) | 2.80692503 |
| 78 | innervation (GO:0060384) | 2.80039169 |
| 79 | auditory behavior (GO:0031223) | 2.78808871 |
| 80 | regulation of neurotransmitter transport (GO:0051588) | 2.78583438 |
| 81 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.78565239 |
| 82 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.74891288 |
| 83 | regulation of vesicle fusion (GO:0031338) | 2.74873315 |
| 84 | regulation of neurotransmitter uptake (GO:0051580) | 2.74494222 |
| 85 | protein polyglutamylation (GO:0018095) | 2.74420012 |
| 86 | positive regulation of exocytosis (GO:0045921) | 2.74160991 |
| 87 | NADH metabolic process (GO:0006734) | 2.73679443 |
| 88 | ribonucleoprotein complex disassembly (GO:0032988) | 2.71933466 |
| 89 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.71895213 |
| 90 | proline transport (GO:0015824) | 2.71440522 |
| 91 | regulation of synaptic plasticity (GO:0048167) | 2.71394587 |
| 92 | alanine transport (GO:0032328) | 2.71045192 |
| 93 | negative regulation of dendrite development (GO:2000171) | 2.70756427 |
| 94 | establishment of protein localization to Golgi (GO:0072600) | 2.70530255 |
| 95 | peristalsis (GO:0030432) | 2.70241985 |
| 96 | long-term synaptic potentiation (GO:0060291) | 2.69389891 |
| 97 | neuron cell-cell adhesion (GO:0007158) | 2.69133843 |
| 98 | regulation of exocytosis (GO:0017157) | 2.68852244 |
| 99 | chemosensory behavior (GO:0007635) | 2.67565522 |
| 100 | regulation of respiratory system process (GO:0044065) | 2.67538756 |
| 101 | positive regulation of neurotransmitter transport (GO:0051590) | 2.66582614 |
| 102 | COPI coating of Golgi vesicle (GO:0048205) | 2.65847044 |
| 103 | Golgi transport vesicle coating (GO:0048200) | 2.65847044 |
| 104 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.63016289 |
| 105 | central nervous system myelination (GO:0022010) | 2.62837559 |
| 106 | axon ensheathment in central nervous system (GO:0032291) | 2.62837559 |
| 107 | regulation of postsynaptic membrane potential (GO:0060078) | 2.62342753 |
| 108 | fear response (GO:0042596) | 2.62207797 |
| 109 | glycosphingolipid biosynthetic process (GO:0006688) | 2.59367449 |
| 110 | regulation of hippo signaling (GO:0035330) | 2.58983164 |
| 111 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.58812082 |
| 112 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.58289484 |
| 113 | dendrite morphogenesis (GO:0048813) | 2.57399071 |
| 114 | neuronal action potential propagation (GO:0019227) | 2.56652535 |
| 115 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.55932428 |
| 116 | behavioral response to ethanol (GO:0048149) | 2.55609479 |
| 117 | righting reflex (GO:0060013) | 2.55344745 |
| 118 | sulfation (GO:0051923) | 2.54648414 |
| 119 | establishment of vesicle localization (GO:0051650) | 2.54160643 |
| 120 | adult walking behavior (GO:0007628) | 2.53377129 |
| 121 | regulation of respiratory gaseous exchange (GO:0043576) | 2.52770130 |
| 122 | DNA deamination (GO:0045006) | 2.52217310 |
| 123 | indolalkylamine metabolic process (GO:0006586) | 2.50526798 |
| 124 | synapse assembly (GO:0007416) | 2.50175308 |
| 125 | protein K11-linked deubiquitination (GO:0035871) | 2.49403085 |
| 126 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.49046176 |
| 127 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.48932138 |
| 128 | positive regulation of fatty acid oxidation (GO:0046321) | 2.48314520 |
| 129 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.48190145 |
| 130 | axon cargo transport (GO:0008088) | 2.47981176 |
| 131 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.47425933 |
| 132 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.46908407 |
| 133 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.46763827 |
| 134 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.46763827 |
| 135 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.46763827 |
| 136 | synaptic transmission (GO:0007268) | 2.46512809 |
| 137 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.46311308 |
| 138 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.45666388 |
| 139 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.45366073 |
| 140 | calcium ion-dependent exocytosis (GO:0017156) | 2.44644166 |
| 141 | behavioral response to cocaine (GO:0048148) | 2.44333355 |
| 142 | kynurenine metabolic process (GO:0070189) | 2.42698981 |
| 143 | indole-containing compound metabolic process (GO:0042430) | 2.42506220 |
| 144 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.42463259 |
| 145 | action potential (GO:0001508) | 2.40238067 |
| 146 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.40148037 |
| 147 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.40148037 |
| 148 | neuron maturation (GO:0042551) | 2.39407203 |
| 149 | central nervous system neuron axonogenesis (GO:0021955) | 2.39364223 |
| 150 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.38454271 |
| 151 | tryptophan catabolic process (GO:0006569) | 2.37372945 |
| 152 | indole-containing compound catabolic process (GO:0042436) | 2.37372945 |
| 153 | indolalkylamine catabolic process (GO:0046218) | 2.37372945 |
| 154 | sodium ion export (GO:0071436) | 2.36903565 |
| 155 | response to histamine (GO:0034776) | 2.36307536 |
| 156 | negative regulation of mast cell activation (GO:0033004) | 2.35905736 |
| 157 | spinal cord development (GO:0021510) | 2.35808026 |
| 158 | regulation of synaptic transmission (GO:0050804) | 2.35160064 |
| 159 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.35031701 |
| 160 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.34339474 |
| 161 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.34339474 |
| 162 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.33958895 |
| 163 | nucleobase catabolic process (GO:0046113) | 2.33639403 |
| 164 | membrane depolarization during action potential (GO:0086010) | 2.33353523 |
| 165 | positive regulation of synaptic transmission (GO:0050806) | 2.32620487 |
| 166 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.32226216 |
| 167 | regulation of oxidative phosphorylation (GO:0002082) | 2.31705081 |
| 168 | negative regulation of cation channel activity (GO:2001258) | 2.31109077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.17592677 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.81896296 |
| 3 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 3.73574092 |
| 4 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.94788995 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.86376514 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.64608231 |
| 7 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.56893748 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.53690763 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.43155400 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.33799250 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.29860276 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.29216585 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.23268092 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.20966502 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.19358205 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.18935322 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.10013666 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.09810724 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01060023 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.92894707 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91503147 |
| 22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82804611 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82336385 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77228303 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76328043 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.76004454 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.74365488 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70385089 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.68285403 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63602813 |
| 31 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.60862311 |
| 32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.60854682 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.60429143 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.57205125 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.57205125 |
| 36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54556887 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.54107607 |
| 38 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.50045096 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48361350 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48027786 |
| 41 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46401218 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46294712 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.42954655 |
| 44 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.41760605 |
| 45 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41760605 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40386339 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40353741 |
| 48 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.39278680 |
| 49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37389689 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37309015 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35119583 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33540965 |
| 53 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33276333 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29454238 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28687234 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28344121 |
| 57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27592861 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27384087 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26463023 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24997081 |
| 61 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.23532032 |
| 62 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21860477 |
| 63 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21641921 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21492385 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18918512 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17951623 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16183927 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15720896 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15207404 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15082206 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14365743 |
| 72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14043611 |
| 73 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13696497 |
| 74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09597359 |
| 75 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09297075 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08738025 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08561790 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08230830 |
| 79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08120830 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07302522 |
| 81 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.06698740 |
| 82 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06052075 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04706135 |
| 84 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.03808091 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03653932 |
| 86 | * AR_19668381_ChIP-Seq_PC3_Human | 1.00628554 |
| 87 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.00614519 |
| 88 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00579767 |
| 89 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00579767 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00349221 |
| 91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00247667 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99660787 |
| 93 | JUN_21703547_ChIP-Seq_K562_Human | 0.99491191 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98725862 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98243135 |
| 96 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97914292 |
| 97 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97410920 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97338957 |
| 99 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97222324 |
| 100 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97109893 |
| 101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.95901055 |
| 102 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.95759828 |
| 103 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95548889 |
| 104 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.95496183 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95441902 |
| 106 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94651429 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94333633 |
| 108 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94132977 |
| 109 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93504529 |
| 110 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.93382160 |
| 111 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92526721 |
| 112 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.92345906 |
| 113 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91136084 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90075058 |
| 115 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89048494 |
| 116 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.88887780 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88865677 |
| 118 | NCOR_22424771_ChIP-Seq_293T_Human | 0.88055999 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85519719 |
| 120 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85356618 |
| 121 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84106317 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82768359 |
| 123 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82768359 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82704027 |
| 125 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.82356055 |
| 126 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82142592 |
| 127 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81970434 |
| 128 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81042640 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.80871602 |
| 130 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.80535309 |
| 131 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79482544 |
| 132 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.78994790 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77539112 |
| 134 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.76250346 |
| 135 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75857480 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.75821655 |
| 137 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.75332290 |
| 138 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.75230304 |
| 139 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.73548449 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73117060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.40863728 |
| 2 | MP0003183_abnormal_peptide_metabolism | 3.28585554 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.16936821 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.14393084 |
| 5 | MP0002735_abnormal_chemical_nociception | 3.04702767 |
| 6 | MP0002736_abnormal_nociception_after | 2.93605668 |
| 7 | MP0009745_abnormal_behavioral_response | 2.79140039 |
| 8 | MP0004270_analgesia | 2.77026051 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.73606405 |
| 10 | MP0002064_seizures | 2.67905990 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.62153463 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.60832461 |
| 13 | MP0003880_abnormal_central_pattern | 2.46029403 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.40507738 |
| 15 | MP0009046_muscle_twitch | 2.33267329 |
| 16 | MP0001986_abnormal_taste_sensitivity | 2.25792790 |
| 17 | MP0002272_abnormal_nervous_system | 2.22974191 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.19167994 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.18934867 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.07543479 |
| 21 | MP0001970_abnormal_pain_threshold | 2.06434015 |
| 22 | MP0005171_absent_coat_pigmentation | 1.96802376 |
| 23 | MP0000015_abnormal_ear_pigmentation | 1.91346072 |
| 24 | MP0003136_yellow_coat_color | 1.90868613 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.85289688 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.78632189 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.71631313 |
| 28 | MP0003879_abnormal_hair_cell | 1.69501666 |
| 29 | MP0003329_amyloid_beta_deposits | 1.69347119 |
| 30 | MP0001485_abnormal_pinna_reflex | 1.69222101 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.68762618 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.68522809 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.61623332 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.59885327 |
| 35 | MP0000604_amyloidosis | 1.56888782 |
| 36 | MP0004142_abnormal_muscle_tone | 1.54185664 |
| 37 | MP0002102_abnormal_ear_morphology | 1.54128971 |
| 38 | MP0003195_calcinosis | 1.54038267 |
| 39 | MP0008569_lethality_at_weaning | 1.53857810 |
| 40 | MP0001486_abnormal_startle_reflex | 1.48386981 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.48138275 |
| 42 | MP0002653_abnormal_ependyma_morphology | 1.47784107 |
| 43 | MP0004130_abnormal_muscle_cell | 1.47006988 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.46140415 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.45782612 |
| 46 | MP0005423_abnormal_somatic_nervous | 1.44960345 |
| 47 | MP0002184_abnormal_innervation | 1.44331618 |
| 48 | MP0005360_urolithiasis | 1.40391670 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.39553569 |
| 50 | MP0004924_abnormal_behavior | 1.39553569 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.32982836 |
| 52 | MP0002928_abnormal_bile_duct | 1.32066081 |
| 53 | MP0004742_abnormal_vestibular_system | 1.31694650 |
| 54 | MP0003646_muscle_fatigue | 1.31633887 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.27400419 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.26712455 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.25871261 |
| 58 | MP0005365_abnormal_bile_salt | 1.25820889 |
| 59 | MP0002229_neurodegeneration | 1.24376866 |
| 60 | MP0003122_maternal_imprinting | 1.24027733 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.22733875 |
| 62 | MP0004858_abnormal_nervous_system | 1.22682422 |
| 63 | MP0002139_abnormal_hepatobiliary_system | 1.22680231 |
| 64 | MP0006072_abnormal_retinal_apoptosis | 1.22616382 |
| 65 | MP0000427_abnormal_hair_cycle | 1.21428015 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.20429701 |
| 67 | MP0008872_abnormal_physiological_respon | 1.17840199 |
| 68 | MP0003283_abnormal_digestive_organ | 1.17813467 |
| 69 | MP0000372_irregular_coat_pigmentation | 1.16780248 |
| 70 | MP0002822_catalepsy | 1.14850803 |
| 71 | MP0001529_abnormal_vocalization | 1.14103213 |
| 72 | MP0003011_delayed_dark_adaptation | 1.13691781 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.12126573 |
| 74 | MP0001984_abnormal_olfaction | 1.11488435 |
| 75 | MP0004133_heterotaxia | 1.11429642 |
| 76 | MP0002095_abnormal_skin_pigmentation | 1.11177292 |
| 77 | MP0002090_abnormal_vision | 1.08609030 |
| 78 | MP0001963_abnormal_hearing_physiology | 1.06272643 |
| 79 | MP0010329_abnormal_lipoprotein_level | 1.05519531 |
| 80 | MP0003868_abnormal_feces_composition | 1.05381935 |
| 81 | MP0005310_abnormal_salivary_gland | 1.05056559 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 1.05046220 |
| 83 | MP0000955_abnormal_spinal_cord | 1.05026044 |
| 84 | MP0002882_abnormal_neuron_morphology | 1.04946020 |
| 85 | MP0008874_decreased_physiological_sensi | 1.04100462 |
| 86 | MP0001666_abnormal_nutrient_absorption | 1.03152012 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 1.02471655 |
| 88 | MP0004510_myositis | 1.00333587 |
| 89 | MP0003633_abnormal_nervous_system | 0.99791404 |
| 90 | MP0003787_abnormal_imprinting | 0.97953588 |
| 91 | MP0005409_darkened_coat_color | 0.97924187 |
| 92 | MP0004381_abnormal_hair_follicle | 0.96210623 |
| 93 | MP0000681_abnormal_thyroid_gland | 0.90790008 |
| 94 | MP0009840_abnormal_foam_cell | 0.90531468 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.90476788 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.90345879 |
| 97 | MP0009697_abnormal_copulation | 0.89013197 |
| 98 | MP0004885_abnormal_endolymph | 0.87614655 |
| 99 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86378715 |
| 100 | MP0005646_abnormal_pituitary_gland | 0.85687012 |
| 101 | MP0005535_abnormal_body_temperature | 0.85255750 |
| 102 | MP0001905_abnormal_dopamine_level | 0.84414616 |
| 103 | MP0000538_abnormal_urinary_bladder | 0.83188318 |
| 104 | MP0005448_abnormal_energy_balance | 0.81794267 |
| 105 | MP0001188_hyperpigmentation | 0.81680933 |
| 106 | MP0003631_nervous_system_phenotype | 0.81053240 |
| 107 | MP0002152_abnormal_brain_morphology | 0.80999942 |
| 108 | MP0000026_abnormal_inner_ear | 0.80022099 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.79943546 |
| 110 | MP0003632_abnormal_nervous_system | 0.79201491 |
| 111 | MP0000371_diluted_coat_color | 0.78852142 |
| 112 | MP0002160_abnormal_reproductive_system | 0.78840958 |
| 113 | MP0000383_abnormal_hair_follicle | 0.78374784 |
| 114 | MP0005670_abnormal_white_adipose | 0.77324762 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.76365692 |
| 116 | MP0001177_atelectasis | 0.76247999 |
| 117 | MP0004043_abnormal_pH_regulation | 0.75685922 |
| 118 | MP0000920_abnormal_myelination | 0.74936090 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.74151896 |
| 120 | MP0003075_altered_response_to | 0.72866189 |
| 121 | MP0005083_abnormal_biliary_tract | 0.72526629 |
| 122 | MP0002638_abnormal_pupillary_reflex | 0.72428782 |
| 123 | MP0005195_abnormal_posterior_eye | 0.71489448 |
| 124 | MP0003866_abnormal_defecation | 0.71446440 |
| 125 | MP0000778_abnormal_nervous_system | 0.71378899 |
| 126 | MP0005377_hearing/vestibular/ear_phenot | 0.71345873 |
| 127 | MP0003878_abnormal_ear_physiology | 0.71345873 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70791801 |
| 129 | MP0001756_abnormal_urination | 0.70460970 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.69015692 |
| 131 | MP0003436_decreased_susceptibility_to | 0.68989009 |
| 132 | MP0008877_abnormal_DNA_methylation | 0.67662185 |
| 133 | MP0003191_abnormal_cellular_cholesterol | 0.66724509 |
| 134 | MP0005253_abnormal_eye_physiology | 0.66454607 |
| 135 | MP0003045_fibrosis | 0.63527284 |
| 136 | MP0002751_abnormal_autonomic_nervous | 0.62803586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.87316985 |
| 2 | Myokymia (HP:0002411) | 4.71829719 |
| 3 | Genetic anticipation (HP:0003743) | 4.65880619 |
| 4 | Visual hallucinations (HP:0002367) | 4.23008554 |
| 5 | Pancreatic cysts (HP:0001737) | 3.47242990 |
| 6 | Epileptic encephalopathy (HP:0200134) | 3.44678756 |
| 7 | Nephronophthisis (HP:0000090) | 3.25670545 |
| 8 | Focal seizures (HP:0007359) | 3.25162791 |
| 9 | Molar tooth sign on MRI (HP:0002419) | 3.23419146 |
| 10 | Abnormality of midbrain morphology (HP:0002418) | 3.23419146 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.20337583 |
| 12 | Neuroendocrine neoplasm (HP:0100634) | 3.18856887 |
| 13 | Pheochromocytoma (HP:0002666) | 3.06971310 |
| 14 | Absence seizures (HP:0002121) | 3.02369905 |
| 15 | Protruding tongue (HP:0010808) | 2.95234529 |
| 16 | Congenital sensorineural hearing impairment (HP:0008527) | 2.94003162 |
| 17 | Absent speech (HP:0001344) | 2.92875637 |
| 18 | Dialeptic seizures (HP:0011146) | 2.90692907 |
| 19 | Attenuation of retinal blood vessels (HP:0007843) | 2.90172666 |
| 20 | Febrile seizures (HP:0002373) | 2.87189950 |
| 21 | True hermaphroditism (HP:0010459) | 2.84713892 |
| 22 | Abnormality of the renal medulla (HP:0100957) | 2.82608064 |
| 23 | Supranuclear gaze palsy (HP:0000605) | 2.77328402 |
| 24 | Abnormality of binocular vision (HP:0011514) | 2.77031243 |
| 25 | Diplopia (HP:0000651) | 2.77031243 |
| 26 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.71977018 |
| 27 | Short 1st metacarpal (HP:0010034) | 2.71977018 |
| 28 | Failure to thrive in infancy (HP:0001531) | 2.70157527 |
| 29 | Poor eye contact (HP:0000817) | 2.69955704 |
| 30 | Hemiparesis (HP:0001269) | 2.69910210 |
| 31 | Clumsiness (HP:0002312) | 2.69433184 |
| 32 | Chronic hepatic failure (HP:0100626) | 2.67177094 |
| 33 | Tubular atrophy (HP:0000092) | 2.66442193 |
| 34 | Abnormality of the renal cortex (HP:0011035) | 2.65452291 |
| 35 | Atonic seizures (HP:0010819) | 2.64631379 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 2.63695234 |
| 37 | Ankle clonus (HP:0011448) | 2.61378576 |
| 38 | Generalized tonic-clonic seizures (HP:0002069) | 2.60887347 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.60321006 |
| 40 | Agitation (HP:0000713) | 2.60248337 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.58725901 |
| 42 | Abnormal social behavior (HP:0012433) | 2.58168232 |
| 43 | Impaired social interactions (HP:0000735) | 2.58168232 |
| 44 | Inability to walk (HP:0002540) | 2.56235117 |
| 45 | Polyphagia (HP:0002591) | 2.51173308 |
| 46 | Type II lissencephaly (HP:0007260) | 2.49627564 |
| 47 | Anxiety (HP:0000739) | 2.49421043 |
| 48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49212573 |
| 49 | Hemiplegia (HP:0002301) | 2.47868376 |
| 50 | Abnormal eating behavior (HP:0100738) | 2.46159643 |
| 51 | Congenital stationary night blindness (HP:0007642) | 2.45221562 |
| 52 | Hypsarrhythmia (HP:0002521) | 2.44883526 |
| 53 | Poor suck (HP:0002033) | 2.40986989 |
| 54 | Cystic liver disease (HP:0006706) | 2.38074142 |
| 55 | Oligomenorrhea (HP:0000876) | 2.36747809 |
| 56 | Hyperventilation (HP:0002883) | 2.34452599 |
| 57 | Abnormal drinking behavior (HP:0030082) | 2.34273613 |
| 58 | Polydipsia (HP:0001959) | 2.34273613 |
| 59 | Focal dystonia (HP:0004373) | 2.33678129 |
| 60 | Abnormality of the nasal septum (HP:0000419) | 2.33460022 |
| 61 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.33002500 |
| 62 | Fetal akinesia sequence (HP:0001989) | 2.31748453 |
| 63 | Abnormality of the 1st metacarpal (HP:0010009) | 2.29717671 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 2.27478358 |
| 65 | Abnormal hair whorl (HP:0010721) | 2.23841387 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22778431 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22778431 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22778431 |
| 69 | Medial flaring of the eyebrow (HP:0010747) | 2.22650364 |
| 70 | Severe visual impairment (HP:0001141) | 2.22402413 |
| 71 | Torticollis (HP:0000473) | 2.21911863 |
| 72 | Psychosis (HP:0000709) | 2.21085745 |
| 73 | Papilledema (HP:0001085) | 2.20958636 |
| 74 | Urinary urgency (HP:0000012) | 2.20813452 |
| 75 | Widely spaced teeth (HP:0000687) | 2.19543194 |
| 76 | Progressive inability to walk (HP:0002505) | 2.17774940 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17354329 |
| 78 | Spastic gait (HP:0002064) | 2.16880477 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.16517982 |
| 80 | Decreased central vision (HP:0007663) | 2.14030738 |
| 81 | Craniofacial dystonia (HP:0012179) | 2.13835361 |
| 82 | Gait imbalance (HP:0002141) | 2.13462832 |
| 83 | Status epilepticus (HP:0002133) | 2.10818922 |
| 84 | Tented upper lip vermilion (HP:0010804) | 2.09327287 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.08317820 |
| 86 | Athetosis (HP:0002305) | 2.07552708 |
| 87 | Ectopic kidney (HP:0000086) | 2.05097788 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05094320 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05094320 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05094320 |
| 91 | Hypothermia (HP:0002045) | 2.03229414 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02738170 |
| 93 | Dysmetria (HP:0001310) | 2.02203765 |
| 94 | Conjugated hyperbilirubinemia (HP:0002908) | 2.00555959 |
| 95 | Progressive microcephaly (HP:0000253) | 2.00249239 |
| 96 | Chorioretinal atrophy (HP:0000533) | 1.99875405 |
| 97 | Bulbous nose (HP:0000414) | 1.99513363 |
| 98 | Increased corneal curvature (HP:0100692) | 1.99469217 |
| 99 | Keratoconus (HP:0000563) | 1.99469217 |
| 100 | Limb dystonia (HP:0002451) | 1.99207655 |
| 101 | Short phalanx of the thumb (HP:0009660) | 1.98899232 |
| 102 | Abnormality of the renal collecting system (HP:0004742) | 1.98482767 |
| 103 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.97339026 |
| 104 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.97127268 |
| 105 | Fair hair (HP:0002286) | 1.96860163 |
| 106 | Abnormality of the lower motor neuron (HP:0002366) | 1.96139028 |
| 107 | Drooling (HP:0002307) | 1.95961230 |
| 108 | Excessive salivation (HP:0003781) | 1.95961230 |
| 109 | Hypoplasia of the pons (HP:0012110) | 1.95849540 |
| 110 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.95656214 |
| 111 | * Spastic tetraplegia (HP:0002510) | 1.95515816 |
| 112 | Broad-based gait (HP:0002136) | 1.95405366 |
| 113 | Depression (HP:0000716) | 1.95330405 |
| 114 | Pendular nystagmus (HP:0012043) | 1.95289180 |
| 115 | Hypoventilation (HP:0002791) | 1.94773535 |
| 116 | Blue irides (HP:0000635) | 1.92564137 |
| 117 | Lissencephaly (HP:0001339) | 1.92551976 |
| 118 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.90833127 |
| 119 | Prolonged QT interval (HP:0001657) | 1.90088928 |
| 120 | Abolished electroretinogram (ERG) (HP:0000550) | 1.89925939 |
| 121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88079152 |
| 122 | Bradykinesia (HP:0002067) | 1.87716068 |
| 123 | Mutism (HP:0002300) | 1.87279147 |
| 124 | Patellar aplasia (HP:0006443) | 1.86970487 |
| 125 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85882423 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.85882423 |
| 127 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.85707241 |
| 128 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.85443407 |
| 129 | Absent/shortened dynein arms (HP:0200106) | 1.85443407 |
| 130 | Macroglossia (HP:0000158) | 1.85346513 |
| 131 | Central scotoma (HP:0000603) | 1.84997366 |
| 132 | Hepatocellular necrosis (HP:0001404) | 1.84986737 |
| 133 | Furrowed tongue (HP:0000221) | 1.84315406 |
| 134 | Muscular hypotonia of the trunk (HP:0008936) | 1.83880074 |
| 135 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.83479273 |
| 136 | Poor speech (HP:0002465) | 1.83430225 |
| 137 | Abnormality of macular pigmentation (HP:0008002) | 1.82526942 |
| 138 | Pachygyria (HP:0001302) | 1.81609359 |
| 139 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.80845152 |
| 140 | Gout (HP:0001997) | 1.80174176 |
| 141 | Cerebral hypomyelination (HP:0006808) | 1.80070502 |
| 142 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79957587 |
| 143 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.78902635 |
| 144 | Ocular albinism (HP:0001107) | 1.78090676 |
| 145 | Abnormality of the pons (HP:0007361) | 1.76460208 |
| 146 | Morphological abnormality of the middle ear (HP:0008609) | 1.76050597 |
| 147 | Amyotrophic lateral sclerosis (HP:0007354) | 1.75691120 |
| 148 | Severe muscular hypotonia (HP:0006829) | 1.75498981 |
| 149 | Action tremor (HP:0002345) | 1.75235125 |
| 150 | Decreased circulating renin level (HP:0003351) | 1.74922016 |
| 151 | Hypoglycemic seizures (HP:0002173) | 1.74206197 |
| 152 | Postural instability (HP:0002172) | 1.73704272 |
| 153 | Axonal loss (HP:0003447) | 1.73582368 |
| 154 | Impaired smooth pursuit (HP:0007772) | 1.73478850 |
| 155 | Hyperactive renin-angiotensin system (HP:0000841) | 1.73036210 |
| 156 | Gaze-evoked nystagmus (HP:0000640) | 1.71462648 |
| 157 | Truncal ataxia (HP:0002078) | 1.71090179 |
| 158 | Tachypnea (HP:0002789) | 1.70594035 |
| 159 | Large for gestational age (HP:0001520) | 1.70547747 |
| 160 | Acute necrotizing encephalopathy (HP:0006965) | 1.70097099 |
| 161 | Duplicated collecting system (HP:0000081) | 1.69953535 |
| 162 | Growth hormone excess (HP:0000845) | 1.68649462 |
| 163 | Rib fusion (HP:0000902) | 1.68354893 |
| 164 | Hepatic necrosis (HP:0002605) | 1.67654475 |
| 165 | Sleep apnea (HP:0010535) | 1.67653872 |
| 166 | Congenital hepatic fibrosis (HP:0002612) | 1.67615863 |
| 167 | Hypoalbuminemia (HP:0003073) | 1.67345849 |
| 168 | Generalized hypopigmentation of hair (HP:0011358) | 1.67053327 |
| 169 | Abnormality of the motor neurons (HP:0002450) | 1.66371417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.94170806 |
| 2 | NTRK3 | 3.63854908 |
| 3 | MAP2K7 | 2.95948955 |
| 4 | MAP3K9 | 2.82325419 |
| 5 | MINK1 | 2.68938780 |
| 6 | CDK19 | 2.68042953 |
| 7 | MAP3K4 | 2.56879453 |
| 8 | MARK1 | 2.56548934 |
| 9 | SIK3 | 2.39569474 |
| 10 | BMPR1B | 2.31142593 |
| 11 | ADRBK2 | 2.22761613 |
| 12 | GRK1 | 2.13460514 |
| 13 | RIPK4 | 2.09969054 |
| 14 | MAP2K4 | 2.01417525 |
| 15 | DAPK2 | 1.86797351 |
| 16 | CAMKK2 | 1.83460485 |
| 17 | CCNB1 | 1.78058148 |
| 18 | CAMK1G | 1.76788441 |
| 19 | NME1 | 1.74928579 |
| 20 | PRPF4B | 1.70183101 |
| 21 | MAP4K2 | 1.69054676 |
| 22 | ACVR1B | 1.68092048 |
| 23 | LIMK1 | 1.66013329 |
| 24 | CAMK1D | 1.65629063 |
| 25 | CAMKK1 | 1.61811837 |
| 26 | KSR1 | 1.58976616 |
| 27 | AKT3 | 1.58345668 |
| 28 | DAPK1 | 1.57914331 |
| 29 | ARAF | 1.56128896 |
| 30 | TLK1 | 1.52961855 |
| 31 | FES | 1.52027495 |
| 32 | MAP3K2 | 1.51349558 |
| 33 | PAK6 | 1.50531892 |
| 34 | EPHA4 | 1.49856605 |
| 35 | TESK1 | 1.45111447 |
| 36 | SGK223 | 1.44530259 |
| 37 | SGK494 | 1.44530259 |
| 38 | FGFR2 | 1.42783922 |
| 39 | PLK2 | 1.39891883 |
| 40 | FER | 1.38762943 |
| 41 | SIK2 | 1.35952073 |
| 42 | TXK | 1.32721904 |
| 43 | CDK5 | 1.31354493 |
| 44 | OXSR1 | 1.30029575 |
| 45 | PNCK | 1.27737250 |
| 46 | PRKD3 | 1.23475740 |
| 47 | SGK2 | 1.22123034 |
| 48 | KSR2 | 1.21888068 |
| 49 | PHKG2 | 1.21700689 |
| 50 | PHKG1 | 1.21700689 |
| 51 | BCR | 1.19738738 |
| 52 | ADRBK1 | 1.19617262 |
| 53 | WNK1 | 1.18270559 |
| 54 | TAOK2 | 1.16178118 |
| 55 | SCYL2 | 1.09081367 |
| 56 | PRKCG | 1.06536470 |
| 57 | PRKD2 | 1.05310292 |
| 58 | STK11 | 1.04853201 |
| 59 | BMPR2 | 1.04638862 |
| 60 | BRSK1 | 1.03311505 |
| 61 | NUAK1 | 1.02965080 |
| 62 | STK24 | 1.01542201 |
| 63 | PTK2B | 0.99186989 |
| 64 | WNK3 | 0.97803740 |
| 65 | CAMK2B | 0.97182283 |
| 66 | CASK | 0.96837286 |
| 67 | SYK | 0.95561677 |
| 68 | IRAK4 | 0.95448178 |
| 69 | MAP3K11 | 0.92305800 |
| 70 | SGK3 | 0.91684619 |
| 71 | NTRK1 | 0.88477704 |
| 72 | TAOK1 | 0.86584704 |
| 73 | ERBB3 | 0.85399706 |
| 74 | BRAF | 0.85356254 |
| 75 | BLK | 0.84095390 |
| 76 | CDK12 | 0.83679996 |
| 77 | INSRR | 0.83477127 |
| 78 | MAPK13 | 0.82615384 |
| 79 | GRK5 | 0.81322622 |
| 80 | MAP3K1 | 0.81176505 |
| 81 | PDPK1 | 0.79466753 |
| 82 | CSNK1A1L | 0.79426651 |
| 83 | CDK18 | 0.78399817 |
| 84 | UHMK1 | 0.78256133 |
| 85 | MAPK15 | 0.75974390 |
| 86 | MUSK | 0.75703640 |
| 87 | PRKCH | 0.73951886 |
| 88 | STK38 | 0.73127692 |
| 89 | TAOK3 | 0.71951366 |
| 90 | CSNK1G2 | 0.71730849 |
| 91 | RET | 0.71686081 |
| 92 | NEK6 | 0.70773477 |
| 93 | CAMK1 | 0.70268285 |
| 94 | PIK3CA | 0.69111444 |
| 95 | PDK1 | 0.69071323 |
| 96 | CAMK4 | 0.68305638 |
| 97 | CAMK2G | 0.68128335 |
| 98 | CDK14 | 0.68072127 |
| 99 | MAPK12 | 0.67736249 |
| 100 | DYRK2 | 0.67533876 |
| 101 | PINK1 | 0.65608002 |
| 102 | SGK1 | 0.65078589 |
| 103 | STK39 | 0.64556195 |
| 104 | MARK2 | 0.64533853 |
| 105 | PRKCZ | 0.63893844 |
| 106 | ERBB2 | 0.63429441 |
| 107 | CAMK2D | 0.63179791 |
| 108 | CDK15 | 0.62160387 |
| 109 | TNIK | 0.62019472 |
| 110 | PRKCE | 0.61200821 |
| 111 | PRKAA1 | 0.59614668 |
| 112 | CAMK2A | 0.59448662 |
| 113 | NTRK2 | 0.58115465 |
| 114 | MAPKAPK3 | 0.57944060 |
| 115 | HIPK2 | 0.57422927 |
| 116 | PKN1 | 0.56359977 |
| 117 | CDC42BPA | 0.56037724 |
| 118 | DYRK1A | 0.55127124 |
| 119 | BRD4 | 0.54551425 |
| 120 | MAP3K13 | 0.54542854 |
| 121 | ZAP70 | 0.53871212 |
| 122 | TGFBR1 | 0.53149278 |
| 123 | TNK2 | 0.50870705 |
| 124 | FRK | 0.50225556 |
| 125 | CSNK1D | 0.50092368 |
| 126 | IRAK3 | 0.49181357 |
| 127 | CDK11A | 0.48447220 |
| 128 | EIF2AK1 | 0.48410308 |
| 129 | MAP2K6 | 0.47865125 |
| 130 | MAP4K1 | 0.47507059 |
| 131 | TRPM7 | 0.47407297 |
| 132 | ALK | 0.46637621 |
| 133 | MAP2K1 | 0.46025022 |
| 134 | TSSK6 | 0.45827409 |
| 135 | TYRO3 | 0.44343600 |
| 136 | WNK4 | 0.44278530 |
| 137 | RPS6KA2 | 0.43832941 |
| 138 | PAK3 | 0.41743015 |
| 139 | PRKAA2 | 0.41404532 |
| 140 | MAPKAPK5 | 0.41215904 |
| 141 | PRKCB | 0.41092222 |
| 142 | RPS6KA3 | 0.41074308 |
| 143 | MAPK8 | 0.40762220 |
| 144 | CSNK1A1 | 0.40340326 |
| 145 | CSNK1G3 | 0.39636693 |
| 146 | FYN | 0.39494465 |
| 147 | PRKACA | 0.39322661 |
| 148 | MAP3K5 | 0.37715850 |
| 149 | PRKCQ | 0.37379688 |
| 150 | KIT | 0.37354415 |
| 151 | PRKG1 | 0.37273514 |
| 152 | ERN1 | 0.35968409 |
| 153 | ROCK2 | 0.35814275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.85289668 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.57530552 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.03805857 |
| 4 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.92013468 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.32438436 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.29735821 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26300745 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.23486164 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.20936059 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.11191913 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.08718388 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.02159701 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.99476190 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.97040691 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.84673715 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.83829213 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80788478 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.72693625 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.67619963 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.62810772 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.62465299 |
| 22 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.60187504 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.58902384 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48015558 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.47918907 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.47864721 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.45953393 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43753772 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.42449317 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.40693707 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.33033575 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.31790608 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.29587676 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29103876 |
| 35 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.29082387 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24833140 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.21944443 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.21411194 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19372667 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.17261678 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16882825 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13161301 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12913423 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08262920 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04139070 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.02414813 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01985490 |
| 48 | Protein export_Homo sapiens_hsa03060 | 0.97162935 |
| 49 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97141969 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96119786 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.91470620 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91276313 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89289961 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88676773 |
| 55 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87629810 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85255957 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84283862 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81622562 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79827419 |
| 60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79513283 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78905094 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77277747 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76797333 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76794181 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76588360 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74949636 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74804805 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74658710 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.74578782 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.74182899 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73912308 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72887681 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72597806 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72159433 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.68600833 |
| 76 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67348700 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66984160 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66788268 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64672423 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63437319 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.62669010 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62412276 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61865777 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60339797 |
| 85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59965094 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59711003 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58797371 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58668530 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.56323804 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56164059 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55849682 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54483221 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54482205 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54062932 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53839601 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52378880 |
| 97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51570080 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51271268 |
| 99 | Proteasome_Homo sapiens_hsa03050 | 0.51076007 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50392343 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.49407265 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.49342156 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48563990 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.47597233 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.46458315 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46007315 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45058448 |
| 108 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44832806 |
| 109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44412542 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44150466 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44078224 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43091899 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42493402 |
| 114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41833275 |
| 115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41742445 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41317671 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41261648 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40085569 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38074978 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37572798 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35870227 |
| 122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35549694 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.35431174 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.35240478 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35238842 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.34221181 |
| 127 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33786880 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.33295971 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31872679 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31285711 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31149965 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.31057167 |
| 133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30553453 |
| 134 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.30249389 |
| 135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29657611 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29488174 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.29130268 |
| 138 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.28444309 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28003423 |
| 140 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.27569469 |
| 141 | Axon guidance_Homo sapiens_hsa04360 | 0.27432999 |
| 142 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27189889 |
| 143 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26858585 |
| 144 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.26704257 |
| 145 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24307746 |
| 146 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.24249022 |
| 147 | Basal transcription factors_Homo sapiens_hsa03022 | 0.23763889 |

